Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: Q95Z88
Term | Name | Level | Count |
---|---|---|---|
GO:0008152 | metabolic process | 1 | 1 |
GO:0032259 | methylation | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0008168 | methyltransferase activity | 4 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 18 | 20 | PF00675 | 0.443 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.410 |
CLV_PCSK_SKI1_1 | 209 | 213 | PF00082 | 0.499 |
DOC_CYCLIN_RxL_1 | 59 | 68 | PF00134 | 0.347 |
DOC_MAPK_gen_1 | 187 | 195 | PF00069 | 0.318 |
DOC_MAPK_MEF2A_6 | 187 | 195 | PF00069 | 0.318 |
DOC_WW_Pin1_4 | 237 | 242 | PF00397 | 0.483 |
LIG_14-3-3_CanoR_1 | 18 | 26 | PF00244 | 0.407 |
LIG_14-3-3_CanoR_1 | 209 | 217 | PF00244 | 0.507 |
LIG_14-3-3_CanoR_1 | 233 | 238 | PF00244 | 0.393 |
LIG_14-3-3_CanoR_1 | 49 | 57 | PF00244 | 0.381 |
LIG_14-3-3_CanoR_1 | 78 | 82 | PF00244 | 0.475 |
LIG_APCC_ABBA_1 | 140 | 145 | PF00400 | 0.376 |
LIG_FHA_1 | 194 | 200 | PF00498 | 0.318 |
LIG_FHA_1 | 234 | 240 | PF00498 | 0.450 |
LIG_FHA_1 | 58 | 64 | PF00498 | 0.422 |
LIG_FHA_2 | 19 | 25 | PF00498 | 0.447 |
LIG_LIR_Apic_2 | 196 | 200 | PF02991 | 0.305 |
LIG_LIR_Gen_1 | 100 | 110 | PF02991 | 0.455 |
LIG_LIR_Gen_1 | 198 | 206 | PF02991 | 0.480 |
LIG_LIR_Gen_1 | 23 | 34 | PF02991 | 0.345 |
LIG_LIR_Nem_3 | 100 | 105 | PF02991 | 0.333 |
LIG_LIR_Nem_3 | 138 | 143 | PF02991 | 0.401 |
LIG_LIR_Nem_3 | 186 | 192 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 198 | 204 | PF02991 | 0.310 |
LIG_LIR_Nem_3 | 222 | 226 | PF02991 | 0.385 |
LIG_LIR_Nem_3 | 229 | 235 | PF02991 | 0.297 |
LIG_LIR_Nem_3 | 23 | 29 | PF02991 | 0.342 |
LIG_LIR_Nem_3 | 90 | 96 | PF02991 | 0.470 |
LIG_Pex14_1 | 16 | 20 | PF04695 | 0.346 |
LIG_Pex14_1 | 197 | 201 | PF04695 | 0.339 |
LIG_Pex14_2 | 140 | 144 | PF04695 | 0.441 |
LIG_SH2_CRK | 102 | 106 | PF00017 | 0.374 |
LIG_SH2_CRK | 223 | 227 | PF00017 | 0.385 |
LIG_SH2_CRK | 93 | 97 | PF00017 | 0.432 |
LIG_SH2_STAP1 | 102 | 106 | PF00017 | 0.424 |
LIG_SH2_STAP1 | 235 | 239 | PF00017 | 0.446 |
LIG_SH2_STAP1 | 81 | 85 | PF00017 | 0.498 |
LIG_SH2_STAT3 | 10 | 13 | PF00017 | 0.394 |
LIG_SH2_STAT3 | 48 | 51 | PF00017 | 0.439 |
LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.426 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.380 |
LIG_SH2_STAT5 | 206 | 209 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 235 | 238 | PF00017 | 0.350 |
LIG_SH3_3 | 236 | 242 | PF00018 | 0.487 |
LIG_TRAF2_1 | 11 | 14 | PF00917 | 0.451 |
LIG_TRAF2_1 | 21 | 24 | PF00917 | 0.387 |
LIG_TYR_ITIM | 199 | 204 | PF00017 | 0.337 |
LIG_TYR_ITIM | 221 | 226 | PF00017 | 0.357 |
LIG_TYR_ITSM | 98 | 105 | PF00017 | 0.420 |
MOD_CK2_1 | 18 | 24 | PF00069 | 0.412 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.433 |
MOD_GlcNHglycan | 101 | 105 | PF01048 | 0.452 |
MOD_GSK3_1 | 205 | 212 | PF00069 | 0.462 |
MOD_GSK3_1 | 233 | 240 | PF00069 | 0.459 |
MOD_GSK3_1 | 65 | 72 | PF00069 | 0.320 |
MOD_N-GLC_1 | 209 | 214 | PF02516 | 0.476 |
MOD_N-GLC_1 | 219 | 224 | PF02516 | 0.348 |
MOD_N-GLC_1 | 57 | 62 | PF02516 | 0.368 |
MOD_N-GLC_1 | 69 | 74 | PF02516 | 0.244 |
MOD_NEK2_1 | 204 | 209 | PF00069 | 0.371 |
MOD_NEK2_1 | 57 | 62 | PF00069 | 0.499 |
MOD_PKA_1 | 18 | 24 | PF00069 | 0.431 |
MOD_PKA_2 | 18 | 24 | PF00069 | 0.381 |
MOD_PKA_2 | 51 | 57 | PF00069 | 0.516 |
MOD_PKA_2 | 77 | 83 | PF00069 | 0.385 |
MOD_Plk_1 | 100 | 106 | PF00069 | 0.423 |
MOD_Plk_1 | 131 | 137 | PF00069 | 0.414 |
MOD_Plk_1 | 219 | 225 | PF00069 | 0.471 |
MOD_Plk_1 | 69 | 75 | PF00069 | 0.288 |
MOD_Plk_2-3 | 149 | 155 | PF00069 | 0.305 |
MOD_Plk_4 | 28 | 34 | PF00069 | 0.430 |
MOD_ProDKin_1 | 237 | 243 | PF00069 | 0.495 |
MOD_SUMO_rev_2 | 76 | 86 | PF00179 | 0.468 |
TRG_ENDOCYTIC_2 | 102 | 105 | PF00928 | 0.380 |
TRG_ENDOCYTIC_2 | 189 | 192 | PF00928 | 0.300 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.297 |
TRG_ENDOCYTIC_2 | 223 | 226 | PF00928 | 0.348 |
TRG_ENDOCYTIC_2 | 26 | 29 | PF00928 | 0.355 |
TRG_ENDOCYTIC_2 | 93 | 96 | PF00928 | 0.438 |
TRG_ER_diArg_1 | 18 | 20 | PF00400 | 0.432 |
TRG_Pf-PMV_PEXEL_1 | 171 | 175 | PF00026 | 0.468 |
TRG_Pf-PMV_PEXEL_1 | 224 | 228 | PF00026 | 0.494 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTY0 | Leptomonas seymouri | 69% | 100% |
A0A0S4IH71 | Bodo saltans | 42% | 93% |
A0A0S4IJP7 | Bodo saltans | 29% | 100% |
A0A0S4J8X8 | Bodo saltans | 41% | 100% |
A0A1X0NMV1 | Trypanosomatidae | 47% | 100% |
A0A3S5H574 | Leishmania donovani | 94% | 100% |
A0A422NN81 | Trypanosoma rangeli | 44% | 100% |
A4H3S8 | Leishmania braziliensis | 87% | 100% |
A4HS03 | Leishmania infantum | 93% | 100% |
C9ZY01 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9AJZ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
P0DPD7 | Homo sapiens | 29% | 96% |
P0DPE0 | Mus musculus | 29% | 96% |
V5BI94 | Trypanosoma cruzi | 46% | 100% |